Lots of info about Gradalis's "Individualized Cancer Therapy", using shRNAi:http://www.faqs.org/patents/app/20140134236
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%